SU999974A3 - Process for producing condensed derivatives of pyrimidine or their salts - Google Patents

Process for producing condensed derivatives of pyrimidine or their salts Download PDF

Info

Publication number
SU999974A3
SU999974A3 SU782897009A SU2897009A SU999974A3 SU 999974 A3 SU999974 A3 SU 999974A3 SU 782897009 A SU782897009 A SU 782897009A SU 2897009 A SU2897009 A SU 2897009A SU 999974 A3 SU999974 A3 SU 999974A3
Authority
SU
USSR - Soviet Union
Prior art keywords
4alkyl
pyrimidine
pyrido
oxo
tetrahydro
Prior art date
Application number
SU782897009A
Other languages
Russian (ru)
Inventor
Хермец Иштван
Месарош Золтан
Биттер Иштван
Хорват Агнеш
Вашвари Лелле
Original Assignee
Хиноин Дьедьсер Еш Ведьесети Термекек Дьяра Рт (Инопредприятие)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хиноин Дьедьсер Еш Ведьесети Термекек Дьяра Рт (Инопредприятие) filed Critical Хиноин Дьедьсер Еш Ведьесети Термекек Дьяра Рт (Инопредприятие)
Application granted granted Critical
Publication of SU999974A3 publication Critical patent/SU999974A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Compounds of the general formula <IMAGE> [wherein R and R<1> are H or C1-4alkyl, or together form (CH=CH)-2, R<2> is H or C1-4alkyl R<3> is H, C1-4alkyl, phenyl, carboxy or salt thereof, alkoxycarbonyl, carbamoyl, cyano, -CO-NH-CO-SO2-C6H4-p-CH3 or -(CH2)s-COOR<14> (s is 1, 2 or 3 and R<14> is H or C1-4alkyl, n is 0 or 1, (a) if R<13> is H, and R<12->R<11> and R<9->R<10> form bonds then YR<7>R<8> represents oxygen or sulfur, or Y represents nitrogen, R<7> is C1-4alkyl, optionally substituted C6-10aryl or C7-12aralkyl, R<8> is a lone pair of electrons or C1-4 alkyl and in this latter case a salt is formed; and XR<4>R<5>R<6> represents halogen; or XR<5>R<6> represents oxygen or sulfur, and R<4> is H or C1-4alkyl, XR<6> represents nitrogen and R<4> is chloroacetyl, C1-4alkyl or optionally substituted C6-10aryl or heteroaryl and R<5> is H or alkyl or (b) if R<11> is H and R<9->R<10> and R<12->R<13> form bonds, then R<4>, R<5>, R<6>, R<7>, R<8>, X and Y are as defined in item (a) and (c) if R<10->R<11> and R<12->R<13> form bonds, then YR<7>R<8>R<9> represents an oxygen or sulfur anion or YR<8>R<9> represents oxygen or sulphur and R<7> is H or C1-4alkyl; or YR<9> represents nitrogen, R<7> is H, C1-4alkyl or optionally substituted C6-10aryl, and R<8> is C1-4alkyl, and XR<4>R<5>R<6> represents halogen or an oxygen or sulfur anion or XR<5>R<6> is O or S and R<4> is H or C1-4alkyl, or XR<6> represents nitrogen, R<4> is chloroacetyl, C1-4alkyl or optionally substituted C6-10aryl or heteroaryl and R<5> is H or C1-4alkyl, and if YR<8>R<9> and XR<5>R<6> each represent oxygen or or sulfur or if YR<9> and XR<6> each represent nitrogen (R<5> and R<8> each being H or C1-4alkyl), then R<4> and R<7> together form optionally substituted -(CH2)-s (s is 1, 2, 3 or 4)] and the tautomers and salts thereof. The compounds have physiological activity.

Description

или их солей, заключающийс  в том, что соединение общей формулы где R, R и п имеют указанные значени , подвергают взаимодействию с сероуглеродом в присутствии катионов щелочного металла, в среде низшего спирта, при комнатной температуре, с последующим выделением Целевого продукта или последующим взаимодействием полученных соединений с этилендигалогенидом , этилендиамином или алки лирующим реагентом и целевые продукты выдел ют в свободном виде или в виде солей. Пример. 5,9 г 3-этоксикар|а56нил-6-метил-4-Ьксо-б ,7,8, 9-тетра1Гидро-4Н-пиридо- (1, 2-а) -пиримидина и 2,3 мл сероуглерода раствор ют в J5 мл этанола и добавл ют к нему по капл м paotBOp 2,8 г гидрата окиси кали  в 25 мл этанола при 25-30°С, Реакционную смесь перемешивают 1 ч при комнатной температуре и выпарива ют при уменьшенном давлении. Получают 9,8 г 3-этокси-карбонил-б-метил-9- (бис-тиолат)-метилен -4-оксо-6 ,7,8,9-тетрагидро-4Н-пиридо(1,2-а) пиридин в виде двукалийной соли. Примв р 2. К раствору 9,7 г 3этоксикарбонил-б-метил-9- С(бис-тиолат метилен}-4-оксо-б,7,8,9-тетрагидро-4Н -пиридо(1,2-а)пиримидин в виде двух-; калийной соли, приготовленного по ме тодике примера 1, в 60 мл (танола до бавллют по капл м при наружномохлаж дении 4,7 мл диметилсульфата иреакционную смесь перемешивают 1 чпри . Выделившиес  желтые кристаллы от45гльтровывают , промывают водой и высуыивают . Получают 7,1 г (86%) 3-это сикарбонил-б-метил-9-(метилтио-тиокарбонил )-4-ОКСО-1,6,7,8-тетрагидро-4Н-пиридо{1 ,2-а)-пиримидина. После Еиерекристаллизации из бензола продук т/лавитс  при 198-199°с. Элементный анализ дл  С гВычислено , %: С 51,51; н 5,56; N 8,58. . Найденр, %: С 51,70; Н 5,78; N 8,48. Пример 3. К раствору 9,7 г 3-этоксикарбонил-6-метил-9-(бис тиолат )-метилен -4-оксо-6,7,8,9-тет рагидро-4н-пиридо(1,2-а)пиримидина в виде двукалийной соли, полученной по методике примера 1, в 60 мл этано ла добавл ют 4,7 г бромистого этилена . Реакционную смесь перемешивают 1 ч при и выделившийс  бромисты натрий отфильровывают. МаточиУй раст вор упаривают наполовину, выделившиес  после охлаждени  кристаллы отфильт ровывают и высушивают. Получают 3 г 3-этоксикарбонил-6-метил-9-(1,3-дитиолан-2-илиден )-4-оксо-б,7,8,9-тетрагидро-4Н-пиридо (1,2-а)пиримидина, - который после перекристаллизации из этанола плавитс  при 205-207 0. Элементный анализ дл  (. Вычислено, %: С 53,28; Н 5,36; .- N 8,27. Найдено, %: С 53,17; Н 5,41; N 8,22. Пример 4. 3,26 г 3-этоксикарбонил-6-метил-9- (метилтио-тиокарбонил )-4-ОКСО-1,б,7,8-тетрагидро-4Н-пиридо (1/2-а)пиримидина в 20 мл ангидрида уксусной кислоты кип т т 2 ч. После охлаждени  выделившиес  кристаллы отфильтровывают, промывают бензолом , и высушивают. Получают 1,6 г (57,6%) 3-этоксикарбонил-6-мётил-9- 4-{3-этоксикарбонил-6-метил-1 ,3-дитиолан-2-илиден -4-оксо-б ,7,8,9тетрагидро-4Н-пиридо (1,2-а)пиримидина , который после кристаллизации из диметилформамида плавитс  при 315318 С ., ./ Элементный анализ дл  С бН 1 4-б 2 Вычислено, %: С 56,10; Н 5,07; N 10,07; S 10,52, Найдено, %: С 55,89;- Н 4,91; N 10,20; S lOfSO. Пример5, 3,26 г 3-этоксикарбонил-6-метил-9- (метилтио-тиокарбонил ) -4-ОКСО-1, 6,7,8-тетрагидро-4Н- . , -пиридо (1,2-а) пиримидина .и 0,6 г .этилендиамина в 50 мл бензола кип т т 10 ч. После охлаждени , выделившиес  желтые кристаллы отфильтровывают, покрывают бензолом и высушивают. Получают 1,9 г (62%) 3-этоксикарбонил-6-метрл-9-{2-имидазолиден )-4-оксо-6 ,7,8,9-тетрагидро-4Н-пиридо{1,2-а)пиримидина , который после перекристаллизации из диметилформамида плавитс  при 252-254С. Элементный, анализ дл  .Оу,. Вычислено, %: С 59,15; Н 5,90; N 18,40. Найдено, %: С 58,91; Н 5,85; N 18,35. Примере. К раствору 0,8 г 3-циано-4-оксо-4,6,7,8-тетрагидро-пирроло- (1,2-а)пиримидина и 0,6 мл сероуглерода в 10 мл этанола добавл ют по капл м раствор 0,6 г гидрата окиси кали  в 10 мл этанола. Реакционную смесь перемешивают 1 ч при комнатной температуре и выпаривают при пониженном давлении. Получают двукалиевую соль З-циано-9-(бис-тиолат)-метилен -4-оксо-4 ,6,7,8-тетрагидропирроло- (1,2-а)пиримидина. П р и м е р 7. Двукалиевую соль циано-9-(бис-тиолат)-метилен -4-оксо-4 ,6,7,8-тетрагидро-пирроло(1,2-а)пиor their salts, which means that the compound of the general formula where R, R and p have the indicated meanings, is reacted with carbon disulfide in the presence of alkali metal cations, in a lower alcohol medium, at room temperature, followed by isolation of the Target Product or by subsequent reaction compounds with ethylene dihalogenide, ethylene diamine or an alkylating reagent and the target products are isolated in free form or in the form of salts. Example. 5.9 g of 3-ethoxycaro-a56nyl-6-methyl-4-bxo-b, 7,8, 9-tetra1Hydro-4H-pyrido- (1, 2-a) -pyrimidine and 2.3 ml of carbon disulfide are dissolved in J5 ml of ethanol and 2.8 g of potassium hydroxide in 25 ml of ethanol are added dropwise to it at 25-30 ° C. The reaction mixture is stirred for 1 hour at room temperature and evaporated under reduced pressure. 9.8 g of 3-ethoxy-carbonyl-b-methyl-9- (bis-thiolate) -methylene-4-oxo-6, 7,8,9-tetrahydro-4H-pyrido (1,2-a) pyridine are obtained in the form of two-potassium salt. Primv p 2. To a solution of 9.7 g of 3ethoxycarbonyl-b-methyl-9-C (methylene bis-thiolate} -4-oxo-b, 7,8,9-tetrahydro-4H-pyrido (1,2-a) pyrimidine in the form of a two-; potassium salt prepared according to the method of example 1 in 60 ml (danol is bavlutt dropwise with external cooling of 4.7 ml of dimethyl sulfate and the reaction mixture is stirred for 1 part. The yellow crystals separated out are washed with 45, washed with water and dried. Obtain 7.1 g (86%) of 3 is sicarbonyl-b-methyl-9- (methylthio-thiocarbonyl) -4-OXO-1,6,7,8-tetrahydro-4H-pyrido {1, 2-a) -pyrimidine. After distillation from benzene, produce / is set at 198-199 ° C. Elemental analysis for C g Calculated,%: C 51.51; n 5.56; N 8.58. Found,%: C 51.70; H 5.78; N 8.48 Example 3. To a solution of 9.7 g of 3-ethoxycarbonyl-6-methyl-9- (bis thiolate) methylene-4-oxo-6,7,8,9-tet rahydro-4n-pyrido (1,2- a) pyrimidine in the form of a two-potassium salt prepared according to the procedure of Example 1, 4.7 g of ethylene bromide was added to 60 ml of ethanol.The reaction mixture was stirred for 1 hour at and the sodium bromide was filtered off. The mother liquor is evaporated by half, the crystals separated out after cooling are filtered and dried. 3 g of 3-ethoxycarbonyl-6-methyl-9- (1,3-dithiolan-2-ylidene) -4-oxo-b, 7,8,9-tetrahydro-4H-pyrido (1,2-a) pyrimidine are obtained - which, after recrystallization from ethanol, melts at 205-207 0. Elemental analysis for (. Calculated,%: C, 53.28; H, 5.36; N- 8.27. Found,%: 53.17; H 5.41; N 8.22. Example 4. 3.26 g of 3-ethoxycarbonyl-6-methyl-9- (methylthio-thiocarbonyl) -4-OXO-1, b, 7,8-tetrahydro-4H-pyrido ( 1/2-a) of pyrimidine in 20 ml of acetic anhydride is boiled for 2 hours. After cooling, the separated crystals are filtered, washed with benzene, and dried to give 1.6 g (57.6%) of 3-ethoxycarbonyl-6-methyl- 9-4- {3- ethoxycarbonyl-6-methyl-1, 3-dithiolan-2-ylidene-4-oxo-b, 7,8,9 tetrahydro-4H-pyrido (1,2-a) pyrimidine, which, after crystallization from dimethylformamide, melts at 315318 ° C. , ./ Elemental analysis for C bN 1 4-b 2 Calculated,%: C 56.10; H 5.07; N 10.07; S 10.52; Found,%: C 55.89; - H 4, 91; N 10.20; S lOfSO. Example 5, 3.26 g of 3-ethoxycarbonyl-6-methyl-9- (methylthio-thiocarbonyl) -4-OXO-1, 6,7,8-tetrahydro-4H-. , -pyrido (1,2-a) pyrimidine and 0.6 g ethylene diamine in 50 ml of benzene are boiled for 10 hours. After cooling, the separated yellow crystals are filtered, covered with benzene and dried. 1.9 g (62%) of 3-ethoxycarbonyl-6-meter-9- {2-imidazolidin) -4-oxo-6 are obtained, 7,8,9-tetrahydro-4H-pyrido {1,2-a) pyrimidine which, after recrystallization from dimethylformamide, melts at 252-254 ° C. Elemental, dl. Oy analysis. Calculated,%: C 59.15; H 5.90; N 18.40. Found,%: C 58.91; H 5.85; N 18.35. Example To a solution of 0.8 g of 3-cyano-4-oxo-4,6,7,8-tetrahydro-pyrrolo- (1,2-a) pyrimidine and 0.6 ml of carbon disulfide in 10 ml of ethanol is added dropwise a solution 0.6 g of potassium hydroxide in 10 ml of ethanol. The reaction mixture is stirred at room temperature for 1 h and evaporated under reduced pressure. A two-potassium salt of Z-cyano-9- (bis-thiolate) -methylene-4-oxo-4, 6,7,8-tetrahydropyrrolo (1,2-a) pyrimidine is obtained. EXAMPLE 7 Cyano-9- (bis-thiolate) methylene-4-oxo-4, 6,7,8-tetrahydro-pyrrolo (1,2-a) pi two-potassium salt

Claims (1)

Формула изобретенияClaim Способ получения конденсированных производных пиримидина Общей формулы <· > .The method of obtaining condensed pyrimidine derivatives of the General formula <·>. tt -пиридо(1,2-а)пиримидина и 0,6 г эти-; 20 ® случае, лендиамина капятят в течение 10 ч?в 50 мл бензола. После охлаждения выпавшие желтые кристаллы отфильтровывают, отжимают с бензолом и высушивают. Получают 1,9 г (69% от теории) 25 З-карбонил-б-метил-9-(2-имидазолиден) · -4-оксо-б,7,8,9-тетрагидро-4Н-пиридо(1,2-а)пиримидина, который после перекристаллизации из_дйметилформамйда плавится при 252-254^0.-pyrido (1,2-a) pyrimidine and 0.6 g of ethi; 20 ® case, lendiamine is dripped for 10 hours in 50 ml of benzene. After cooling, the yellow crystals precipitated are filtered off, squeezed with benzene and dried. 1.9 g (69% of theory) of 25-carbonyl-b-methyl-9- (2-imidazolidene) -4-oxo-b, 7.8.9-tetrahydro-4H-pyrido (1.2) are obtained. -a) pyrimidine, which after recrystallization from dimethylformamide melts at 252-254 ^ 0. Элементный анализ дляElemental analysis for Вычислено,%: С 59.,1'5*;~Н 5,9и;Calculated,%: С 59., 1'5 *; ~ Н 5.9и; 18,40.18.40. 58,91; Н 5,85;58.91; H 5.85; 18,35.18.35. где R — атом водорода или Cj-Cj-алкил; R — алкоксикарбонил с 2-5 атомами углерода или циангруппа;where R is a hydrogen atom or Cj-Cj-alkyl; R is alkoxycarbonyl with 2-5 carbon atoms or a cyano group; η = 0 или 1, Ί η = 0 or 1, Ί а) в случае, когда R — атом водорода, ' R^ HR6, а также R’ и R4 являются до.. полнительной связью, х и у означают серу, R2- - С^-алкил, или , когда R6h R7, а такжеa) in the case when R is a hydrogen atom, 'R ^ HR 6 , as well as R' and R 4 are an .. additional bond, x and y are sulfur, R 2 is C ^ -alkyl, or when R 6 h R 7 as well R4 и R5 являются дополнительной связью, х и у означают атомы серы с отрицательным зарядом, a R2 и R® являются катионом щелочного металла, или ; х и у являются атомами серы или группой формулы >Ν - Η, Λ ” но являются группой формулы . -(СН^)^или их. солей, отличающийся тем, что соединение общей формулы a R1 и R5 совмест30R 4 and R 5 are an additional bond, x and y are negatively charged sulfur atoms, and R 2 and R® are an alkali metal cation, or; x and y are sulfur atoms or a group of the formula> Ν - Η, Λ ”but are a group of the formula. - (CH ^) ^ or them. salts, characterized in that the compound of the general formula a R 1 and R 5 are compatible30 NN Найдено, %: СFound,%: C N ιN ι '· 4 ·'· 4 · Растворяют 1,0 г З-этоксикарбонил-б-метил-9-(2-имидазолйлен)-4-оксо-б,7,8,9-тетрагидро-4Н-пиридо(1,2-а)пиримидина в 10 мл Ьтанола. Раствор насыщают газообразным хлористым водородом и испаряют. Остаток перекристаллизовывают из смеси эфира и этанола. Получают 0,9 г бис-гйдрохлорида З-этоксикарбонил-6- 45 -метил-9-(2-имидаэолиден)-4-оксо-б, 7,8,9-тетрагидро-4Н-пиридо(.1,2-а) пиримидина, который, плавится с разложени-.Dissolve 1.0 g of 3-ethoxycarbonyl-b-methyl-9- (2-imidazolylene) -4-oxo-b, 7,8,9-tetrahydro-4H-pyrido (1,2-a) pyrimidine in 10 ml of ethanol . The solution was saturated with gaseous hydrogen chloride and evaporated. The residue was recrystallized from a mixture of ether and ethanol. 0.9 g of 3-ethoxycarbonyl-6- 45-methyl-9- (2-imidaeoliden) -4-oxo-b, 7.8,9-tetrahydro-4H-pyrido (.1,2-a) is obtained ) pyrimidine, which melts with decomposition. 59,15, 18,40. 58,91; Н 5,85;59.15, 18.40. 58.91; H 5.85; 18,35.18.35. ем при 190“с. Элементный Вычислено,eat at 190 “s. Elemental Calculated Найдено, %:Found,%: анализ дляanalysis for СFROM NN СFROM N %:N%:
SU782897009A 1977-12-29 1978-12-28 Process for producing condensed derivatives of pyrimidine or their salts SU999974A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77CI1793A HU185925B (en) 1977-12-29 1977-12-29 Process for preparing compounds with nitrogen bridge head

Publications (1)

Publication Number Publication Date
SU999974A3 true SU999974A3 (en) 1983-02-23

Family

ID=10994682

Family Applications (3)

Application Number Title Priority Date Filing Date
SU782897009A SU999974A3 (en) 1977-12-29 1978-12-28 Process for producing condensed derivatives of pyrimidine or their salts
SU782704102A SU1072807A3 (en) 1977-12-29 1978-12-28 Process for preparing derivatives of pyrido-(1,2-a)-pyrimidine,or their acid additions salts,or their optical isomers
SU802897056A SU1082324A3 (en) 1977-12-29 1980-03-20 Process for preparing condensed derivatives of pyrimidine or their salts

Family Applications After (2)

Application Number Title Priority Date Filing Date
SU782704102A SU1072807A3 (en) 1977-12-29 1978-12-28 Process for preparing derivatives of pyrido-(1,2-a)-pyrimidine,or their acid additions salts,or their optical isomers
SU802897056A SU1082324A3 (en) 1977-12-29 1980-03-20 Process for preparing condensed derivatives of pyrimidine or their salts

Country Status (8)

Country Link
JP (1) JPS54106496A (en)
BE (1) BE873193A (en)
CH (1) CH641456A5 (en)
DE (1) DE2854113A1 (en)
FR (1) FR2413388A1 (en)
GB (1) GB2011406B (en)
HU (1) HU185925B (en)
SU (3) SU999974A3 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU183330B (en) * 1981-02-13 1984-04-28 Chinoin Gyogyszer Es Vegyeszet Process for producing new of 2,4,8-triazaphenalenium-salts
AR046938A1 (en) * 2003-12-12 2006-01-04 Merck & Co Inc PROCEDURE TO PREPARE HEXAHYDROPIRIMID [1,2-A] AZEPIN-2-CARBOXYLATES AND SIMILAR COMPUTERS
WO2016182780A1 (en) * 2015-05-12 2016-11-17 E I Du Pont De Nemours And Company Aryl substituted bicyclic compounds as herbicides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU168014B (en) * 1973-03-30 1976-02-28
US3898224A (en) * 1974-09-09 1975-08-05 Squibb & Sons Inc 1,6,7,8-Tetrahydro-4-oxo-4H-pyrido {8 1,2-A{9 pyrimidine-9-carboalkoxy compounds
US3965100A (en) * 1975-02-26 1976-06-22 E. R. Squibb & Sons, Inc. 2,3-Dihydrocyclopenta[d]pyrido[1,2-a]pyrimidin-10(1H)-one and its derivatives
HU174693B (en) * 1976-02-12 1980-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing condensed pyrimidine derivatives

Also Published As

Publication number Publication date
SU1072807A3 (en) 1984-02-07
GB2011406A (en) 1979-07-11
DE2854113A1 (en) 1979-07-12
FR2413388B1 (en) 1982-03-26
GB2011406B (en) 1982-09-08
CH641456A5 (en) 1984-02-29
BE873193A (en) 1979-04-17
JPS54106496A (en) 1979-08-21
SU1082324A3 (en) 1984-03-23
HU185925B (en) 1985-04-28
FR2413388A1 (en) 1979-07-27

Similar Documents

Publication Publication Date Title
SU602118A3 (en) Method of producing benzimidazole derivatives or salts thereof
SU589915A3 (en) Method of preparing substituted benzazoles
JPH0314315B2 (en)
SU999974A3 (en) Process for producing condensed derivatives of pyrimidine or their salts
SU645566A3 (en) Method of obtaining pyrazols
US3176017A (en) Aroylalkyl derivatives of diazabicyclo-nonanes and-decanes
SU694075A3 (en) Method of preparing 6-methyl-8-substituted-methylergolines or their salts
DE2435382A1 (en) PYRIMIDOBENZOTHIADIAZEPINE AND PYRIMIDOTHIADIAZOCINE AND THEIR DIOXIDES, METHOD FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS
US2621162A (en) J-propargyl-x-quinazolones and acid
JPS62161766A (en) Imidazole n-oxide compound and manufacture
US2729645A (en) 1-[2-(dithiocarboxyamino)polymethylene] quaternary ammonium inner salts
US4292431A (en) Process for the production of hydroxymethylimidazoles
US4108894A (en) Amidines
SU728718A3 (en) Method of preparing triazolothieno-diazepin-1-ones
KR900003652B1 (en) Process for preparation of antiallergic compounds
KR840001669B1 (en) Process for the preparation of octadecenic acid amide
RU2303599C1 (en) METHOD FOR PRODUCTION OF SUBSTITUTED PYRIDO[3&#39;,2&#39;:4,5]IMIDAZO[1,2-α]PYRIDINES
JPS6019314B2 (en) 2,3,6,7↓-tetrahydro↓-3↓-oxo↓-5H↓-pyridazino[3,4↓-b][1,4]oxazine derivative
SU143810A1 (en) The method of obtaining n-alkoxy derivatives of n&#39;-bis- (beta-chloroethyl) aminomethyl-isobenzene
JPS6261966A (en) Propionamidine derivatives and manufacture
US3277096A (en) Process for the preparation of aminohalogeno isoquinolines
SU437284A1 (en) Method for preparing indeno-pyridine derivatives
US2775608A (en) Sulfonic acid esters of 2-dialkylamine ethanols
SU1342899A1 (en) Method of producing 2-amino-2-methylpropanthiosulfuric acid
FI61878C (en) PROCEDURE FOR FRAMSTATION OF AV 1-EECL-2- (2&#39;-METOXY-5&#39;-SULPHONAMIDOBENSOYL) -AMINOMETHYLPYRROLIDINE